Vitrolife AB (GB:0YAY)
LSE:0YAY
Holding GB:0YAY?
Track your performance easily

Vitrolife AB (0YAY) Share Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

0YAY Analyst Ratings

Currently, no data available
Based on 0 analysts giving stock ratings to
Vitrolife
AB
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

0YAY Stock 12 Month Forecast

There Are No Analyst Ratings for GB:0YAY In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

0YAY Financial Forecast

0YAY Earnings Forecast

Next quarter’s earnings estimate for 0YAY is kr1.14 with a range of kr1.02 to kr1.29. The previous quarter’s EPS was kr1.06. 0YAY beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 36.73% of the time in the same period. In the last calendar year 0YAY has Outperformed its overall industry.
Next quarter’s earnings estimate for 0YAY is kr1.14 with a range of kr1.02 to kr1.29. The previous quarter’s EPS was kr1.06. 0YAY beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 36.73% of the time in the same period. In the last calendar year 0YAY has Outperformed its overall industry.

0YAY Sales Forecast

Next quarter’s sales forecast for 0YAY is kr918.44M with a range of kr892.00M to kr954.00M. The previous quarter’s sales results were kr941.00M. 0YAY beat its sales estimates 25.00% of the time in past 12 months, while its overall industry beat sales estimates 49.32% of the time in the same period. In the last calendar year 0YAY has Underperformed its overall industry.
Next quarter’s sales forecast for 0YAY is kr918.44M with a range of kr892.00M to kr954.00M. The previous quarter’s sales results were kr941.00M. 0YAY beat its sales estimates 25.00% of the time in past 12 months, while its overall industry beat sales estimates 49.32% of the time in the same period. In the last calendar year 0YAY has Underperformed its overall industry.

0YAY Analyst Recommendation Trends

Rating
Jun 23
Jul 23
Strong Buy
1
2
Buy
0
0
Hold
0
0
Sell
0
0
Strong Sell
0
0
total
1
2
In the current month, 0YAY has received 2 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 0YAY average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

0YAY Stock Forecast FAQ

What is GB:0YAY’s average 12-month price target, according to analysts?
Currently, no data Available
What is GB:0YAY’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for GB:0YAY, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is Vitrolife AB a Buy, Sell or Hold?
      Currently, no data Available
      What is Vitrolife AB’s share price target?
      Currently, no data Available
      What do analysts say about Vitrolife AB?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of Vitrolife AB?
      To buy shares of GB:0YAY, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis